Skip to main content

MoneyWorks4Me

Amanta Healthcare - Quaterly Results

04 Nov 2026 Evaluate
The Revenue for the quarter ended  September 2026 of Rs. 831.32 millions grew by 17.27 % from Rs. 708.87 millions.The company almost doubled its revenue to Rs. 48.62 millions  from Rs. 12.07 millions in the quarter ended September 2026.The company reported a good operating profit of 179.51 millions compared to 147.21 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 831.32 708.87 17.27 1519.35 1361.94 11.56 2876.77 2747.08 4.72
Other Income 7.55 0.71 963.38 13.98 10.32 35.47 33.71 13.85 143.39
PBIDT 179.51 147.21 21.94 331.33 305.76 8.36 632.28 610.53 3.56
Interest 58.44 51.52 13.43 118.49 114.39 3.58 207.46 279.48 -25.77
PBDT 121.07 69.40 74.45 212.84 165.08 28.93 398.53 331.05 20.38
Depreciation 52.80 46.63 13.23 99.65 93.04 7.10 187.30 183.99 1.80
PBT 68.27 22.77 199.82 113.19 72.04 57.12 211.23 147.06 43.64
TAX 19.65 10.70 83.64 31.47 24.89 26.44 62.49 42.06 48.57
Deferred Tax 12.65 -8.97 -241.03 20.99 -11.30 -285.75 -23.40 6.14 -481.11
PAT 48.62 12.07 302.82 81.72 47.15 73.32 148.74 105.00 41.66
Equity 388.29 388.29 0.00 388.29 388.29 0.00 343.36 282.70 21.46
PBIDTM(%) 21.59 20.77 3.98 21.81 22.45 -2.86 21.98 22.22 -1.11
Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..